Real‐World Outcomes of Omalizumab for Chronic Spontaneous Urticaria in a New Zealand Regional Dermatology Service
Australasian Journal of Dermatology · 2026-11 · 67 (7)
DOI: 10.1111/ajd.70185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australasian Journal of Dermatology, online erschienen am 24.07.2026. Verfasst von Jeffrey Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Waikato Hospital, Health New Zealand Waikato, Hamilton, New Zealand. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Waikato Hospital, Health New Zealand Waikato, Hamilton, New Zealand.
- Auckland University, Waikato Clinical Campus, Hamilton, New Zealand.
ORCID-Profile: Jeffrey Lee, Karen Koch
Zitieren
APA
Lee, J., & Koch, K. (2026). Real‐World Outcomes of Omalizumab for Chronic Spontaneous Urticaria in a New Zealand Regional Dermatology Service. Australasian Journal of Dermatology, 67(7). https://doi.org/10.1111/ajd.70185
Vancouver
Lee J, Koch K. Real‐World Outcomes of Omalizumab for Chronic Spontaneous Urticaria in a New Zealand Regional Dermatology Service. Australasian Journal of Dermatology. 2026;67(7). doi:10.1111/ajd.70185
BibTeX
@article{Lee2026,
author = {Lee, Jeffrey and Koch, Karen},
title = {Real‐World Outcomes of Omalizumab for Chronic Spontaneous Urticaria in a New Zealand Regional Dermatology Service},
journal = {Australasian Journal of Dermatology},
year = {2026},
volume = {67},
number = {7},
doi = {10.1111/ajd.70185}
}
EUVIMED